Bio Medica Laboratories (NSE:BMLL) Quick Ratio: 0.76 (As of Mar. 2025) — 49% Above Median


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories Quick Ratio?

Bio Medica Laboratories NSE:BMLL +0.49% 14 Quick Ratio is 0.76 as of Mar. 2025, which is 49% above its 10-year median of 0.51. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Bio Medica Laboratories ranks worse than 85.36% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Bio Medica Laboratories's quick ratio for the quarter that ended in Mar. 2025 was 0.76.

Bio Medica Laboratories has a quick ratio of 0.76. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Bio Medica Laboratories's Quick Ratio or its related term are showing as below:

NSE:BMLL' s Quick Ratio Range Over the Past 10 Years
Min: 0.49   Med: 0.51   Max: 0.76
Current: 0.76

During the past 3 years, Bio Medica Laboratories's highest Quick Ratio was 0.76. The lowest was 0.49. And the median was 0.51.

NSE:BMLL's Quick Ratio is ranked worse than
85.36% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs NSE:BMLL: 0.76

Bio Medica Laboratories  (NSE:BMLL) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Bio Medica Laboratories Quick Ratio Related Terms


Bio Medica Laboratories Quick Ratio Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Quick Ratio Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
Quick Ratio
0.51 0.49 0.76

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
Quick Ratio 0.51 0.49 0.76

NSE:BMLL vs ISRG, BDX, MDLN: Quick Ratio Comparison

For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Medica Laboratories Quick Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Bio Medica Laboratories's Quick Ratio falls into.


NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Bio Medica Laboratories's Quick Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Quick Ratio (A: Mar. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(310.912-181.379)/169.943
=0.76

Bio Medica Laboratories's Quick Ratio for the quarter that ended in Mar. 2025 is calculated as

Quick Ratio (Q: Mar. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(310.912-181.379)/169.943
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.76 mean?
Bio Medica Laboratories (NSE:BMLL) has a Quick Ratio of 0.76 as of Mar. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio Medica Laboratories and its competitors. This is 49% above median its historical median of 0.51. Over the past decade, Bio Medica Laboratories' Quick Ratio has ranged from 0.49 to 0.76. According to the industry distribution chart, Bio Medica Laboratories ranks #729 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 85.4%.
Is Bio Medica Laboratories' Quick Ratio too high?
Bio Medica Laboratories' current Quick Ratio of 0.76 is 49% above median its 10-year median of 0.51. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 0.76. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Bio Medica Laboratories' value of 0.76 is 59.2% below this industry median. Based on the distribution chart, Bio Medica Laboratories ranks #729 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #729 out of 854 companies for Quick Ratio. This places Bio Medica Laboratories in the lower half of its industry. The industry median Quick Ratio is 1.87. Bio Medica Laboratories' value of 0.76 is 59.2% below this benchmark. Historically, Bio Medica Laboratories' own Quick Ratio has ranged from 0.49 to 0.76 over the past decade. While the company's 10-year median is 0.51 vs. the industry median of 1.87, Bio Medica Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Medica Laboratories's current Quick Ratio of 0.76 is 59.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio Medica Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current Quick Ratio is 0.76, which is 49% above median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Quick Ratio of 0.76. The current Quick Ratio is 0.76, which is 49% above median its 10-year median of 0.51 and 59.2% below the Medical Devices & Instruments industry median of 1.87. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Quick Ratio is 0.76 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price